332 related articles for article (PubMed ID: 3601985)
21. T cell activation and cellular cooperation in autoimmune NZB/NZW F hybrid mice.
Roder JC; Bell DA; Singhal SK
J Immunol; 1975 Aug; 115(2):466-72. PubMed ID: 1097516
[TBL] [Abstract][Full Text] [Related]
22. The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice.
Adam C; Thoua Y; Ronco P; Verroust P; Tovey M; Morel-Maroger L
Clin Exp Immunol; 1980 May; 40(2):373-82. PubMed ID: 6160000
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies.
Gunn HC
Clin Exp Immunol; 1986 May; 64(2):225-33. PubMed ID: 3488856
[TBL] [Abstract][Full Text] [Related]
24. Treatment of lupus nephritis in adult (NZB + NZW)F1 mice by cortisone-facilitated tolerance to nucleic acid antigens.
Borel Y; Lewis RM; André-Schwartz J; Stollar BD; Diener E
J Clin Invest; 1978 Feb; 61(2):276-86. PubMed ID: 304453
[TBL] [Abstract][Full Text] [Related]
25. Does the deletion within T cell receptor beta-chain gene of NZW mice contribute to autoimmunity in (NZB X NZW)F1 mice?
Yanagi Y; Hirose S; Nagasawa R; Shirai T; Mak TW; Tada T
Eur J Immunol; 1986 Sep; 16(9):1179-82. PubMed ID: 3758154
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice.
Carlsten H; Holmdahl R; Tarkowski A
Immunology; 1991 Jun; 73(2):186-90. PubMed ID: 2071164
[TBL] [Abstract][Full Text] [Related]
27. Sequential study of C 1 q-binding substances and of anti-DNA antibodies in (NZB X NZW)F1 mice: evidence for an acute phase of the lupus disease in 2-month-old mice.
Fournié GJ; Gayral-Ta Minh M; Haas S; Pourrat JP; Conte JJ
Eur J Immunol; 1979 Aug; 9(8):652-4. PubMed ID: 499331
[TBL] [Abstract][Full Text] [Related]
28. Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) or cyclosporin A treated (NZB X NZW) F1 mice.
Israel-Biet D; Noel LH; Bach MA; Dardenne M; Bach JF
Clin Exp Immunol; 1983 Nov; 54(2):359-65. PubMed ID: 6360436
[TBL] [Abstract][Full Text] [Related]
29. Requirement of H-2 heterozygosity for autoimmunity in (NZB X NZW)F1 hybrid mice.
Hirose S; Ueda G; Noguchi K; Okada T; Sekigawa I; Sato H; Shirai T
Eur J Immunol; 1986 Dec; 16(12):1631-3. PubMed ID: 2949983
[TBL] [Abstract][Full Text] [Related]
30. Correlations of autoimmunity with H-2 and T cell receptor beta chain genotypes in (NZB X NZW) F2 mice.
Noonan DJ; McConahey PJ; Cardenas GJ
Eur J Immunol; 1990 May; 20(5):1105-10. PubMed ID: 1972678
[TBL] [Abstract][Full Text] [Related]
31. Anti-tumor effects of allogeneic bone marrow transplantation in (NZB X NZW)F1 hybrids with spontaneous lymphosarcoma.
Moscovitch M; Slavin S
J Immunol; 1984 Feb; 132(2):997-1000. PubMed ID: 6361137
[TBL] [Abstract][Full Text] [Related]
32. Treatment with high doses of anti-IgM prevents, but with lower doses accelerates autoimmune disease in (NZW x BXSB)F1 hybrid mice.
Cerny A; Starobinski M; Hügin AW; Sutter S; Zinkernagel RM; Izui S
J Immunol; 1987 Jun; 138(12):4222-8. PubMed ID: 3495583
[TBL] [Abstract][Full Text] [Related]
33. Studies of tolerance to DNA in NZB/NZW F1 mice.
Tanphaichtr K; Hahn BH
J Immunol; 1977 Jul; 119(1):330-6. PubMed ID: 301536
[TBL] [Abstract][Full Text] [Related]
34. [Effect of anti-idiotypic antibody on production of anti-DNA antibodies by splenocytes in lupus prone mice].
Sugishima H; Minoda M
Arerugi; 1991 Jul; 40(7):711-8. PubMed ID: 1929883
[TBL] [Abstract][Full Text] [Related]
35. Acceleration of autoimmunity in NZB/NZW F1 mice by graft-versus-host disease.
Goldblum R; Pillarisetty R; Dauphinee MJ; Talal N
Clin Exp Immunol; 1975 Feb; 19(2):377-85. PubMed ID: 2403
[TBL] [Abstract][Full Text] [Related]
36. Abnormal polyclonal B cell activation in NZB/NZW F1 mice.
Cohen PL; Ziff M
J Immunol; 1977 Oct; 119(4):1534-7. PubMed ID: 561128
[TBL] [Abstract][Full Text] [Related]
37. Comparison of T cell-mediated immune responsiveness of NZB, (NZB x &NZW)F1 hybrid and other murine strains.
Zinkernagel RM; Dixon FJ
Clin Exp Immunol; 1977 Jul; 29(1):110-21. PubMed ID: 142594
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic MHC antigen requirements for lupus-like autoantibody production and nephritis in murine graft-vs-host disease.
Portanova JP; Ebling FM; Hammond WS; Hahn BH; Kotzin BL
J Immunol; 1988 Nov; 141(10):3370-6. PubMed ID: 3263424
[TBL] [Abstract][Full Text] [Related]
39. In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon.
Jacob CO; van der Meide PH; McDevitt HO
J Exp Med; 1987 Sep; 166(3):798-803. PubMed ID: 3114409
[TBL] [Abstract][Full Text] [Related]
40. Autoantibodies to anti-DNA with anti-allotypic and anti-idiotypic specificities in (NZB X NZW)F1 mice.
Eilat D; Fischel R; Zlotnick A
Eur J Immunol; 1985 Apr; 15(4):375-81. PubMed ID: 2580714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
